It was only when he saw that a study of 17,000 patients by Harvard Medical School concluded that patients who were prescribed semaglutide had a higher incidence of developing NAION than those who were not taking the drug
Ive been dealing with it for nearly 11 months, and did physical therapy for 3 months with less progress than Ive had in 2 weeks following your advice
Clinical approach considerations: Patient selection: Stable post-surgical patients with inadequate weight loss, weight regain, or persistent metabolic disease Timing: Individualized based on weight trajectory and metabolic status, often when weight loss plateaus or regain is documented Baseline evaluation: Comprehensive metabolic panel, nutritional markers (vitamin B12, iron studies, vitamin D, calcium, albumin), HbA1c if diabetic, lipid panel, assessment of gastrointestinal symptoms, renal function Dosing strategy: For Wegovy, initiate at 0.25 mg weekly with gradual titration (0.250.51.01.72.4 mg)
Protein intake should increase to 1.2-1.6g per kilogram during transitions
Research shows that someone who has lost significant weight burns 200-500 fewer calories daily than someone who naturally weighs the same amount
